Ganglioside catabolism is altered in fibroblasts and leukocytes from Alzheimer's disease patients
Open Access
- 30 September 2006
- journal article
- editorial
- Published by Elsevier in Neurobiology of Aging
- Vol. 27 (9) , 1354-1356
- https://doi.org/10.1016/j.neurobiolaging.2005.06.012
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Up-regulation of Glycohydrolases in Alzheimer's Disease Fibroblasts Correlates with Ras ActivationJournal of Biological Chemistry, 2003
- Leukocyte Lysosomal Enzymes in Alzheimer's Disease and Down's SyndromeThe Journals of Gerontology: Series A, 2002
- The interaction between Alzheimer amyloid β(1–40) peptide and ganglioside GM1‐containing membranesFEBS Letters, 1997
- Colocalization of Lysosomal Hydrolase and β-Amyloid in Diffuse Plaques of the Cerebellum and Striatum in Alzheimerʼs Disease and Downʼs SyndromeJournal of Neuropathology and Experimental Neurology, 1996
- A biomarker that identifies senescent human cells in culture and in aging skin in vivo.Proceedings of the National Academy of Sciences, 1995
- Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.Proceedings of the National Academy of Sciences, 1991
- Brain Gangliosides in Dementia of the Alzheimer TypeArchives of Neurology, 1989
- Topographical Atlas of the Gangliosides of the Adult Human BrainJournal of Neurochemistry, 1984
- Gangliosides in the nervous systemNeurochemistry International, 1983
- Glycosphingolipids in Cellular Interaction, Differentiation, and OncogenesisAnnual Review of Biochemistry, 1981